Bilateral Atypical Femur Fracture in a Patient Under Bisphosphonate Treatment Bifosfonat ile tedavi olan hastada çift taraflĩ atipik femur kĩrĩğĩ


Karamanlĩoğlu D. S., Kaysin M., Badur N. B., ÜNLÜ ÖZKAN F., AKTAŞ İ.

Turkish Journal of Endocrinology and Metabolism, cilt.23, sa.3, ss.187-190, 2019 (Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23 Sayı: 3
  • Basım Tarihi: 2019
  • Doi Numarası: 10.25179/tjem.2018-64415
  • Dergi Adı: Turkish Journal of Endocrinology and Metabolism
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.187-190
  • Anahtar Kelimeler: Atypical fractures, bisphosphonates, osteoporosis
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Osteoporosis is a systemic skeletal disease that affects most of the elderly people. Bisphosphonate is an effective anti-resorptive drug widely used for the prevention and treatment of osteoporosis. However, recent evidence has linked longterm bisphosphonate use with an atypical fracture. We report a case of a 79-year-old woman who had been on bisphosphonate treatment for eight years and presented with bilateral femur diaphyseal fractures occurring within an interval of a few months. The physicians must consider the possibility of atypical fractures with the fresh onset of groin or mid-thigh pain in patients who have been on bisphosphonate therapy, particularly for more than five years.